FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India

Suchitra Swaminathan; Swati Garg; Manisha Madkaikar; Maya Gupta; Farah Jijina; Kanjaksha Ghosh

doi:10.4103/0971-6866.142884

Home

Current Issue

Archives

Guidelines

Subscriptions

e-Alerts

Users online: 15

ORIGINAL ARTICLE

Year : 2014 \| Volume : 20 \| Issue : 2 \| Page : 160-165

FLT3 and NPM-1 mutations in a cohort of acute promyelocytic leukemia patients from India Suchitra Swaminathan¹, Swati Garg², Manisha Madkaikar², Maya Gupta², Farah Jijina³, Kanjaksha Ghosh² ¹ Department of Pediatric Immunology and Leukocyte Biology, National Institute of Immunohaematology, Indian Council of Medical Research, K.E.M. Hospital, Parel, Mumbai, Maharashtra, India; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA, ² Department of Pediatric Immunology and Leukocyte Biology, National Institute of Immunohaematology, Indian Council of Medical Research, K.E.M. Hospital, Parel, Mumbai, Maharashtra, India, ³ Department of Hematology, K.E.M. Hospital, Parel, Mumbai, Maharashtra, India, Correspondence Address: Kanjaksha Ghosh National Institute of Immunohaematology, Indian Council of Medical Research, 13^th Floor, NMS building, K.E.M. Hospital, Parel, Mumbai - 400 012, Maharashtra, India Source of Support: None, Conflict of Interest: None DOI: 10.4103/0971-6866.142884

Background: Acute promyelocytic leukemia (APL) with t (15;17) is a distinct category of acute myeloid leukemia (AML) and is reported to show better response to anthracyclin based chemotherapy. A favorable overall prognosis over other subtypes of AML has been reported for APL patients but still about 15% patients relapse. Methods: This study evaluated the presence of Famus like tyrosine kinase-3 (FLT3) and nucleophosmin-1 (NPM1) gene mutations in a cohort of 40 APL patients. Bone marrow/peripheral blood samples from patients at the time of diagnosis and follow-up were processed for immunophenotyping, cytogenetic markers and isolation of DNA and RNA. Samples were screened for the presence of mutations in FLT3 and NPM1 genes using polymerase chain reaction followed by sequencing. Results: Frequency of FLT3/internal tandem duplication and FLT3/tyrosine kinase domain was found to be 25% and 7% respectively. We observed a high frequency of NPM1 mutation (45%) in the present population of APL patients.



[FULL TEXT] [PDF]*

Table of Contents

Similar in PUBMED

Search Pubmed for

Search in Google Scholar for

Related articles

Citation Manager

Access Statistics

Reader Comments

Email Alert *

Add to My List *

* Requires registration (Free)

Article Access Statistics

Viewed	931

Printed	20

Emailed	0

PDF Downloaded	79

Comments	[Add]